Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic Anemia
- 21 September 1989
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 321 (12) , 784-789
- https://doi.org/10.1056/nejm198909213211203
Abstract
To determine the incidence of secondary cancers after bone marrow transplantation, we reviewed the records of all patients at our center who received allogeneic, syngeneic, or autologous transplants for leukemia (n = 1926) or aplastic anemia (n = 320).This publication has 47 references indexed in Scilit:
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- Bone Sarcomas Linked to Radiotherapy and Chemotherapy in ChildrenNew England Journal of Medicine, 1987
- Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's DiseaseNew England Journal of Medicine, 1987
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Recurrence of Ph′-Positive Leukemia in Donor Cells after Marrow Transplantation for Chronic Granulocytic LeukemiaNew England Journal of Medicine, 1984
- Radiation CarcinogenesisNew England Journal of Medicine, 1984
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983
- Leukemia Relapse in Donor Cells after Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1981
- FAILURE OF EARLY ADMINISTRATION OF ANTITHYMOCYTE GLOBULIN TO LESSEN GRAFT-VERSUS-HOST DISEASE IN HUMAN ALLOGENEIC MARROW TRANSPLANT RECIPIENTSTransplantation, 1981
- Immunoblastic Sarcoma in Donor Cells after Bone-Marrow TransplantationNew England Journal of Medicine, 1979